慢性阻塞性肺病患者的铁平衡与预后之间的关联:从MIMIC-IV数据库的回顾性分析
Zhenchao Dong1, Chaoqun Xu2, Shanjun Yu3
1The People's Hospital of Danyang and Affiliated Danyang Hospital of Nantong University, Danyang, China.
Frontiers in medicine
|June 30, 2025
概括
铁的生物标志物,如血清铁和费里丁,表明慢性阻塞性肺病 (COPD) 的预后不佳. 相反,转激素和总结铁能力 (TIBC) 可能会保护COPD患者的死亡率.
科学领域:
- 肺部医学 肺部医学
- 生物标志物研究 生物标志物研究
- 临床流行病学临床流行病学
背景情况:
- 已知炎症反应会影响铁代谢的生物标志物.
- 慢性阻塞性肺病 (COPD) 中与铁相关的生物标志物的预后影响尽管具有炎症性,但仍未得到充分研究.
研究的目的:
- 研究关键铁相关生物标志物与COPD患者的长期和住院死亡率之间的关联.
- 评估这些生物标志物对COPD预后的预测能力.
主要方法:
- 在MIMIC-IV数据库中对611名COPD患者的临床数据进行了回顾性分析.
- 利用考克斯回归和卡普兰-梅尔生存分析来评估生物标志物与死亡率的关联.
- 使用接收器运行特征 (ROC) 曲线来确定预后预测值.
主要成果:
- 血清铁和费里丁水平升高与COPD患者的长期预后较差有显著联系.
- 较高的转移素和总结铁能力 (TIBC) 水平与长期死亡风险降低有关.
- 所有四个评估的铁生物标志物都显示出对长期和住院死亡率有一定的预测价值.
结论:
- 与铁相关的生物标志物与COPD患者的预后有着关键的联系,为风险分层提供了潜在的可能性.
- 研究结果为COPD患者的临床管理提供了宝贵的见解.
- 建议对动态铁生物标志物变化的进一步研究,以加强COPD治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
COPD: Pathogenesis and Clinical Features
535
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
535
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K


